Senti Biosciences Inc (SNTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,286 | 58 | 1,766 | 1,358 | 1,104 |
| Gross Profit | 1,286 | 58 | 1,766 | 1,358 | 1,104 |
| Operating Expenses | 16,250 | 13,865 | 16,514 | 23,129 | 12,862 |
| Operating Income | -14,964 | -13,807 | -14,748 | -21,771 | -11,758 |
| Other Income | 1,112 | 1,805 | 445 | 10,219 | -50 |
| Pre-tax Income | -13,852 | -12,002 | -14,303 | -11,552 | -11,808 |
| Net Income Continuous | -13,852 | -12,002 | -14,303 | -11,552 | -11,808 |
| Net Income Discontinuous | -4,870 | -6,208 | -2,337 | N/A | N/A |
| Net Income | $-18,722 | $-18,210 | $-16,640 | $-11,552 | $-11,808 |
| EPS Basic Total Ops | -4.20 | 27.30 | -3.80 | -8.60 | -37.20 |
| EPS Basic Continuous Ops | -3.10 | 30.13 | -3.30 | -8.59 | -37.24 |
| EPS Basic Discontinuous Ops | -1.10 | -2.80 | -0.50 | N/A | N/A |
| EPS Diluted Total Ops | -4.20 | 27.30 | -3.80 | -8.60 | -37.20 |
| EPS Diluted Continuous Ops | -3.10 | 30.13 | -3.30 | -8.59 | -37.24 |
| EPS Diluted Discontinuous Ops | -1.10 | -2.80 | -0.50 | N/A | N/A |
| EBITDA(a) | $-14,035 | $-12,863 | $-13,717 | $-20,836 | $-10,748 |